Stay updated on Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial page.

Latest updates to the Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedA site-wide notice announces updates and FAQs about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and navigation with an access-denied message. This indicates that the study details are currently unavailable on the site.SummaryDifference16%

- Check57 days agoChange DetectedAn NIH grant/contract identifier was added to the study's identifiers, providing funding source context. The site revision label was updated from v3.6.5 to v3.6.6, indicating a minor page/template update.SummaryDifference0.0%

- Check64 days agoChange DetectedA new Related Info section, the sponsor name Boehringer Ingelheim, and a Helpful Links Provided by header were added to the Study Details page to organize supplementary information and showcase sponsor-provided resources.SummaryDifference0.1%

Stay in the know with updates to Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial page.